{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:03:54Z","timestamp":1760234634820,"version":"build-2065373602"},"reference-count":31,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Attention Deficit Hyperactivity Disorder (ADHD) is raising concerns across health systems, affecting about 5% of the school-age population. Therapy usually involves psychostimulants, which are prone to adverse drug reactions (ADRs). Teachers have many contact hours with children and can easily detect behavioral changes upon the beginning of medication. However, few studies have focused on the role of teachers in the management of ADHD children and detection of ADRs. The present work aimed to characterize the perception of primary school teachers regarding the impact of ADHD therapeutics. A questionnaire was constructed focused on teachers\u2019 training regarding ADHD and its therapy; experience with students with ADHD; changes upon beginning of medication; and observation of ADRs. A total of 107 completed questionnaires were obtained. The results indicate that more than 40% of the inquired teachers have received training in ADHD, but in most cases, the theme of therapeutics was absent from that training. The vast majority of teachers (91.6%) have had students with ADHD and observed mood alterations associated with medications. More than 60% of the teachers answered that they are aware of the ADRs and of these, 24% have already detected them in their students. The teachers reported the observed ADRs to parents in 93% of the cases and to doctors in 28% of the cases. In conclusion, the results show the need to reinforce teachers\u2019 training in ADHD and its therapeutics.<\/jats:p>","DOI":"10.3390\/ijerph18126233","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T14:16:04Z","timestamp":1623248164000},"page":"6233","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Perception of Primary School Teachers Regarding the Pharmacotherapy of Attention Deficit Hyperactivity Disorder"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6130-9453","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Greg\u00f3rio","sequence":"first","affiliation":[{"name":"CBIOS, Research Center for Biosciences & Health Technologies, Universidade Lus\u00f3fona\u2019s, 1749-024 Lisboa, Portugal"}]},{"given":"Raquel","family":"Ferreira","sequence":"additional","affiliation":[{"name":"CBIOS, Research Center for Biosciences & Health Technologies, Universidade Lus\u00f3fona\u2019s, 1749-024 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6350-0641","authenticated-orcid":false,"given":"Ana Sofia","family":"Fernandes","sequence":"additional","affiliation":[{"name":"CBIOS, Research Center for Biosciences & Health Technologies, Universidade Lus\u00f3fona\u2019s, 1749-024 Lisboa, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). APA Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_2","unstructured":"(2020, September 17). NICE. Attention Deficit Hyperactivity Disorder: Diagnosis and Management, Available online: https:\/\/www.nice.org.uk\/guidance\/ng87."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41380-018-0070-0","article-title":"Genetics of attention deficit hyperactivity disorder","volume":"24","author":"Faraone","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3928\/00904481-20150313-13","article-title":"Assessment and treatment of attention-deficit\/hyperactivity disorder: Part 1","volume":"44","author":"French","year":"2015","journal-title":"Pediatr. Ann."},{"key":"ref_5","first-page":"43","article-title":"PHDA: Afinal, qual a sua origem? Uma revis\u00e3o dos fatores etiol\u00f3gicos","volume":"51","author":"Oliveira","year":"2017","journal-title":"Rev. Port. Da Pedagog."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ije\/dyt261","article-title":"ADHD prevalence estimates across three decades: An updated systematic review and meta-regression analysis","volume":"43","author":"Polanczyk","year":"2014","journal-title":"Int. J. Epidemiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0269881113519509","article-title":"Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology","volume":"28","author":"Nutt","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/phar.2192","article-title":"Impact of central nervous system stimulant medication use on growth in pediatric populations with attention-deficit\/hyperactivity disorder: A review","volume":"39","author":"Troksa","year":"2019","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/phar.1455","article-title":"Drugs associated with adverse events in children and adolescents","volume":"34","author":"Lee","year":"2014","journal-title":"Pharmacotherapy"},{"key":"ref_10","first-page":"29744873","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents\u2014Assessment of adverse events in non-randomised studies","volume":"5","author":"Pedersen","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1207\/s15324826an1202_7","article-title":"Teachers\u2019 perceptions of the incidence and management of attention-deficit hyperactivity disorder","volume":"12","author":"Havey","year":"2005","journal-title":"Appl. Neuropsychol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lee, J., Grizenko, N., Bhat, V., Sengupta, S., Polotskaia, A., and Joober, R. (2011). Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD. BMC Psychiatry, 11.","DOI":"10.1186\/1471-244X-11-70"},{"key":"ref_13","first-page":"34","article-title":"Cross-national comparisons of teachers\u2019 knowledge and misconceptions of ADHD","volume":"5","author":"Sciutto","year":"2016","journal-title":"Int. Perspect. Psychol. Res. Pract. Consult."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0829573514542225","article-title":"Nova Scotia teachers\u2019 ADHD knowledge, beliefs, and classroom management practices","volume":"30","author":"Martin","year":"2015","journal-title":"Can. J. Sch. Psychol."},{"key":"ref_15","unstructured":"EMA (2018). Spontaneous Adverse Drug Reactions\u2014Subgroup Report."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug Saf."},{"key":"ref_17","unstructured":"WHO (2010). Minimum Requirements for a Functzional Pharmacovigilance System, World Health Organization."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00228-011-1096-2","article-title":"A plea for a more epidemiological and patient-oriented pharmacovigilance","volume":"68","author":"Scurti","year":"2012","journal-title":"Eur. J. Clin. Pharm."},{"key":"ref_19","unstructured":"EMA (2019). 2018 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hasan, S.S., Bal, N., Baker, I., Kow, C.S., and Khan, M.U. (2021). Adverse drug reaction reporting and prescribing trends of drugs for attention deficit hyperactivity disorder in primary care england, 2010\u20132019. J. Atten. Disord., 108705472199755.","DOI":"10.1177\/1087054721997556"},{"key":"ref_21","unstructured":"Romanini, L.S.M. (2012). Perturba\u00e7\u00e3o de Hiperatividade com D\u00e9fice de Aten\u00e7\u00e3o: Import\u00e2ncia do Envolvimento Parental no Percurso Escolar\u2014Estudo de Caso Comparativo. [Ph.D. Thesis, Instituto Polit\u00e9cnico de Castelo Branco]."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e20152749","DOI":"10.1542\/peds.2015-2749","article-title":"Diagnostic accuracy of rating scales for attention-deficit\/hyperactivity disorder: A meta-analysis","volume":"137","author":"Chang","year":"2016","journal-title":"Pediatrics"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/ipm.2017.62","article-title":"Attention-deficit hyperactivity disorder: A clinical review of the concept, diagnosis and management","volume":"35","author":"Kelly","year":"2018","journal-title":"Ir. J. Psychol. Med."},{"key":"ref_24","unstructured":"DGEEC, and DSEE (2018). Perfil do Docente 2016\/2017."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1089\/cap.2013.0114","article-title":"Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit\/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate","volume":"24","author":"Ramtvedt","year":"2014","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/01.chi.0000125089.35109.81","article-title":"Relapse prevention in pediatric patients with ADHD treated with atomoxetine: A randomized, double-blind, placebo-controlled study","volume":"43","author":"Michelson","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/11586050-000000000-00000","article-title":"Parental reporting of adverse drug reactions associated with attention-deficit hyperactivity disorder (ADHD) medications in children attending specialist paediatric clinics in the UK","volume":"34","author":"Tobaiqy","year":"2011","journal-title":"Drug Saf."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.sapharm.2016.02.008","article-title":"How to best manage time interaction with patients? Community pharmacist workload and service provision analysis","volume":"13","author":"Cavaco","year":"2017","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s11096-015-0140-1","article-title":"The organizational framework of community pharmacies in Europe","volume":"37","author":"Martins","year":"2015","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.sapharm.2019.02.005","article-title":"Preparing the health workforce to enhance medication safety","volume":"15","author":"Cordina","year":"2019","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1089\/cyber.2018.0711","article-title":"Interactive avatar boosts the performances of children with attention deficit hyperactivity disorder in dynamic measures of intelligence","volume":"22","author":"Fabio","year":"2019","journal-title":"Cyberpsychology Behav. Soc. Netw."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/12\/6233\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:12:24Z","timestamp":1760163144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/12\/6233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["ijerph18126233"],"URL":"https:\/\/doi.org\/10.3390\/ijerph18126233","relation":{},"ISSN":["1660-4601"],"issn-type":[{"type":"electronic","value":"1660-4601"}],"subject":[],"published":{"date-parts":[[2021,6,9]]}}}